Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Age-Related Macular Degeneration

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Age-Related Macular Degeneration in 1 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birke, K1
Lipo, E1
Birke, MT1
Kumar-Singh, R1

Other Studies

1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Age-Related Macular Degeneration

ArticleYear
Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Administration, Topical; Animals; Choroidal Neovascularization; Complement Activation; Complement Me

2013